P-777 Perinatal and neonatal outcomes, along with a long-term follow-up of children, following Capacitation In-vitro Maturation (CAPA-IVM) in women with predicted excessive ovarian response
L N Vuong, T D Pham, V N Ho, H L Le, A H Le, H H Pham, C T Tran, A N Ha, T K Le, T T Le, X T Le, M H Nguyen, B G Huynh, T M Ho
{"title":"P-777 Perinatal and neonatal outcomes, along with a long-term follow-up of children, following Capacitation In-vitro Maturation (CAPA-IVM) in women with predicted excessive ovarian response","authors":"L N Vuong, T D Pham, V N Ho, H L Le, A H Le, H H Pham, C T Tran, A N Ha, T K Le, T T Le, X T Le, M H Nguyen, B G Huynh, T M Ho","doi":"10.1093/humrep/deaf097.1081","DOIUrl":null,"url":null,"abstract":"Study question What are the perinatal, neonatal outcomes and long-term development of children following CAPA-IVM in women with predicted excessive response to ovarian stimulation? Summary answer Cumulative live birth rate following CAPA-IVM was 37.8%. Perinatal, neonatal and long-term developmental outcomes of children born after CAPA-IVM were within the expected normal range. What is known already CAPA-IVM may be considered a viable alternative to In-vitro Fertilization (IVF) in women with predicted excessive ovarian stimulation. Results from a randomized controlled trial comparing CAPA-IVM and IVF did not demonstrate the inferiority of CAPA-IVM following the first transfer. Existing evidence on perinatal and neonatal outcomes following CAPA-IVM indicated that CAPA-IVM yields outcomes comparable to those of IVF. However, there is a paucity of data regarding the cumulative live birth rate and long-term follow-up of children born from CAPA-IVM. Study design, size, duration We have documented the perinatal and neonatal outcomes of 1,563 CAPA-IVM cycles performed at a tertiary IVF centerfrom January 2016 to December 2023. Additionally, a long-term follow-up study was conducted on children born from a randomized controlled trial (RCT) comparing CAPA-IVM and IVF, initiated in 2018. The follow-up assessments were carried out when the children were at the ages of 6 months, 12 months, 24 months, and 60 months. Participants/materials, setting, methods Cumulative live birth rate was calculated after utilizing all embryos generated from a single CAPA-IVM cycle. Low birth weight was defined as less than 2,500 grams, while high birth weight was defined as greater than 4,000 grams. Congenital anomalies was reported according to the ICD-10 system. Children were followed up to 60 months of age and assessed for weight, height, BMI, and psychomotor development using the Ages and Stages Questionnaires (ASQ-3) and Red Flag signs. Main results and the role of chance The analysis encompassed a total of 1,563 CAPA-IVM cycles, which included 2,016 embryo transfer cycles, culminating in the birth of 658 children. Among these children, 432 were singletons and 226 were twins. The cumulative live birth rate was 37.8%. The rates of hypertension, gestational diabetes mellitus, and preterm birth were 3.5%, 15%, and 24%, respectively. Mean birth weight for singletons was 3,084.1±620.7g, while for twins was 2,458.9±679.8g. The low birth weight rate was 15%, and high birth weight was 2.5%. Congenital anomalies were observed in 1.5% of the children. In a RCT comparing CAPA-IVM and IVF, 94 children born from CAPA-IVM were compared with 104 children born from IVF at 6 months, 12 months, and 24 months of age. The two groups were comparable in terms of ASQ-3 scores. At 60 months, 36 children born after CAPA-IVM were compared with 52 children born after IVF. There were no significant differences in weightand BMI between two groups, but children born from CAPA-IVM was significantly shorter than those born from IVF (112.0 [Q1-Q3: 110.0; 115.0] vs. 115.5 [Q1-Q3: 110.0; 120.0] cm, p = 0.02). Additionally, there were no differences in ASQ-3 scores and the rates of Red Flag signs. Limitations, reasons for caution The comparison of ASQ-3 scores is underpowered and a small sample size of children followed up to 60 months. Additionally, there is no comparison to children conceived through spontaneous conception. Wider implications of the findings CAPA-IVM demonstrates favorable live birth outcomes. Longitudinal data indicate that the developmental trajectories of children conceived through CAPA-IVM are comparable to those of children born following IVF. CAPA-IVM may be considered as an alternative for managing infertility in women predicted an excessive ovarian response. Trial registration number No","PeriodicalId":13003,"journal":{"name":"Human reproduction","volume":"26 1","pages":""},"PeriodicalIF":6.0000,"publicationDate":"2025-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Human reproduction","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/humrep/deaf097.1081","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Study question What are the perinatal, neonatal outcomes and long-term development of children following CAPA-IVM in women with predicted excessive response to ovarian stimulation? Summary answer Cumulative live birth rate following CAPA-IVM was 37.8%. Perinatal, neonatal and long-term developmental outcomes of children born after CAPA-IVM were within the expected normal range. What is known already CAPA-IVM may be considered a viable alternative to In-vitro Fertilization (IVF) in women with predicted excessive ovarian stimulation. Results from a randomized controlled trial comparing CAPA-IVM and IVF did not demonstrate the inferiority of CAPA-IVM following the first transfer. Existing evidence on perinatal and neonatal outcomes following CAPA-IVM indicated that CAPA-IVM yields outcomes comparable to those of IVF. However, there is a paucity of data regarding the cumulative live birth rate and long-term follow-up of children born from CAPA-IVM. Study design, size, duration We have documented the perinatal and neonatal outcomes of 1,563 CAPA-IVM cycles performed at a tertiary IVF centerfrom January 2016 to December 2023. Additionally, a long-term follow-up study was conducted on children born from a randomized controlled trial (RCT) comparing CAPA-IVM and IVF, initiated in 2018. The follow-up assessments were carried out when the children were at the ages of 6 months, 12 months, 24 months, and 60 months. Participants/materials, setting, methods Cumulative live birth rate was calculated after utilizing all embryos generated from a single CAPA-IVM cycle. Low birth weight was defined as less than 2,500 grams, while high birth weight was defined as greater than 4,000 grams. Congenital anomalies was reported according to the ICD-10 system. Children were followed up to 60 months of age and assessed for weight, height, BMI, and psychomotor development using the Ages and Stages Questionnaires (ASQ-3) and Red Flag signs. Main results and the role of chance The analysis encompassed a total of 1,563 CAPA-IVM cycles, which included 2,016 embryo transfer cycles, culminating in the birth of 658 children. Among these children, 432 were singletons and 226 were twins. The cumulative live birth rate was 37.8%. The rates of hypertension, gestational diabetes mellitus, and preterm birth were 3.5%, 15%, and 24%, respectively. Mean birth weight for singletons was 3,084.1±620.7g, while for twins was 2,458.9±679.8g. The low birth weight rate was 15%, and high birth weight was 2.5%. Congenital anomalies were observed in 1.5% of the children. In a RCT comparing CAPA-IVM and IVF, 94 children born from CAPA-IVM were compared with 104 children born from IVF at 6 months, 12 months, and 24 months of age. The two groups were comparable in terms of ASQ-3 scores. At 60 months, 36 children born after CAPA-IVM were compared with 52 children born after IVF. There were no significant differences in weightand BMI between two groups, but children born from CAPA-IVM was significantly shorter than those born from IVF (112.0 [Q1-Q3: 110.0; 115.0] vs. 115.5 [Q1-Q3: 110.0; 120.0] cm, p = 0.02). Additionally, there were no differences in ASQ-3 scores and the rates of Red Flag signs. Limitations, reasons for caution The comparison of ASQ-3 scores is underpowered and a small sample size of children followed up to 60 months. Additionally, there is no comparison to children conceived through spontaneous conception. Wider implications of the findings CAPA-IVM demonstrates favorable live birth outcomes. Longitudinal data indicate that the developmental trajectories of children conceived through CAPA-IVM are comparable to those of children born following IVF. CAPA-IVM may be considered as an alternative for managing infertility in women predicted an excessive ovarian response. Trial registration number No
研究问题:预测卵巢刺激反应过度的女性CAPA-IVM术后围产儿、新生儿结局和儿童长期发展情况如何?CAPA-IVM术后的累计活产率为37.8%。CAPA-IVM术后患儿的围产期、新生儿和长期发育结局均在预期正常范围内。已知的CAPA-IVM可能被认为是预测卵巢过度刺激的女性体外受精(IVF)的可行替代方案。一项比较CAPA-IVM和IVF的随机对照试验的结果没有显示CAPA-IVM在首次移植后的劣势。关于CAPA-IVM后围产期和新生儿结局的现有证据表明,CAPA-IVM的结果与IVF相当。然而,关于CAPA-IVM出生的儿童的累积活产率和长期随访的数据缺乏。我们记录了2016年1月至2023年12月在三级IVF中心进行的1563次CAPA-IVM周期的围产期和新生儿结局。此外,对2018年启动的一项比较CAPA-IVM和IVF的随机对照试验(RCT)中出生的儿童进行了一项长期随访研究。在儿童6个月、12个月、24个月和60个月时进行随访评估。参与者/材料、环境、方法利用单个CAPA-IVM周期产生的所有胚胎后计算累积活产率。低出生体重被定义为小于2500克,而高出生体重被定义为大于4000克。根据ICD-10系统报告先天性异常。随访儿童至60个月大,并使用年龄和阶段问卷(ASQ-3)和红旗标志评估体重、身高、BMI和精神运动发展。该分析共包括1563个CAPA-IVM周期,其中包括2016个胚胎移植周期,最终导致658名儿童的出生。在这些孩子中,432人是单胎,226人是双胞胎。累计活产率为37.8%。高血压、妊娠期糖尿病和早产的发生率分别为3.5%、15%和24%。单胎平均出生体重为3084.1±620.7g,双胞胎平均出生体重为2458.9±679.8g。低出生体重率为15%,高出生体重率为2.5%。1.5%的患儿有先天性异常。在一项比较CAPA-IVM和IVF的随机对照试验中,94名通过CAPA-IVM出生的儿童与104名在6个月、12个月和24个月时通过IVF出生的儿童进行了比较。两组在ASQ-3得分方面具有可比性。在60个月时,36名在CAPA-IVM后出生的儿童与52名在IVF后出生的儿童进行了比较。两组间体重和BMI无显著差异,但CAPA-IVM出生的孩子明显短于IVF出生的孩子(112.0 [Q1-Q3: 110.0;115.0 vs 115.5 [Q1-Q3: 110.0;120.0] cm, p = 0.02)。此外,在ASQ-3得分和红旗信号的发生率上没有差异。ASQ-3评分的比较能力不足,而且对儿童的随访时间长达60个月,样本量很小。此外,这与自然受孕的孩子没有可比性。研究结果的更广泛意义CAPA-IVM显示了有利的活产结局。纵向数据表明,通过CAPA-IVM受孕的儿童的发育轨迹与体外受精后出生的儿童相当。CAPA-IVM可能被认为是治疗卵巢反应过度的妇女不孕症的一种替代方法。试验注册号
期刊介绍:
Human Reproduction features full-length, peer-reviewed papers reporting original research, concise clinical case reports, as well as opinions and debates on topical issues.
Papers published cover the clinical science and medical aspects of reproductive physiology, pathology and endocrinology; including andrology, gonad function, gametogenesis, fertilization, embryo development, implantation, early pregnancy, genetics, genetic diagnosis, oncology, infectious disease, surgery, contraception, infertility treatment, psychology, ethics and social issues.